Unknown

Dataset Information

0

Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.


ABSTRACT:

Background and objectives

Sodium bicarbonate has been proposed for protection of the kidney from contrast-induced AKI (CIAKI). However, the effects of bicarbonate on long-term important clinical outcomes are uncertain.

Design, setting, participants, & measurements

In a prospective, double-blind, multicenter randomized clinical trial, 391 patients with an eGFR<45 ml/min per 1.73 m(2) undergoing elective coronary or peripheral angiography were randomized to an infusion with a high dose of isotonic sodium bicarbonate (target 2.0 mEq/kg) or a similar molar amount of isotonic sodium chloride. The primary outcome was a composite of mortality, dialysis, or a sustained 20% reduction in eGFR at 6 months.

Results

There were 391 patients enrolled between March 2010 and May 2012. The incidence of the primary outcome was 14.9% in the bicarbonate group and 16.3% in the control group in the intention-to-treat population (P=0.78). There was also no difference in the incidence of CIAKI between the treatment groups (14.5% versus 12.1%, respectively; P=0.20). CIAKI was associated with a higher incidence of sustained loss of kidney function at 6 months compared with those without CIAKI (21.2% versus 7.7%, respectively; P=0.06).

Conclusions

High-dose sodium bicarbonate infusion in patients with eGFR<45 ml/min per 1.73 m(2) undergoing angiography did not demonstrate a difference in incidence of the composite of death, dialysis, or sustained 6-month reduction in eGFR or CIAKI compared with sodium chloride.

SUBMITTER: Solomon R 

PROVIDER: S-EPMC4559510 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.

Solomon Richard R   Gordon Paul P   Manoukian Steven V SV   Abbott J Dawn JD   Kereiakes Dean J DJ   Jeremias Allen A   Kim Michael M   Dauerman Harold L HL  

Clinical journal of the American Society of Nephrology : CJASN 20150716 9


<h4>Background and objectives</h4>Sodium bicarbonate has been proposed for protection of the kidney from contrast-induced AKI (CIAKI). However, the effects of bicarbonate on long-term important clinical outcomes are uncertain.<h4>Design, setting, participants, & measurements</h4>In a prospective, double-blind, multicenter randomized clinical trial, 391 patients with an eGFR<45 ml/min per 1.73 m(2) undergoing elective coronary or peripheral angiography were randomized to an infusion with a high d  ...[more]

Similar Datasets

| S-EPMC4902357 | biostudies-literature
| S-EPMC6801223 | biostudies-literature
| S-EPMC4358464 | biostudies-literature
| S-EPMC5805164 | biostudies-literature
| S-EPMC2693108 | biostudies-literature
| S-EPMC5753317 | biostudies-literature
| S-EPMC2706243 | biostudies-literature
| S-EPMC8517125 | biostudies-literature
| S-EPMC4354054 | biostudies-literature
| S-EPMC3559541 | biostudies-literature